nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Nervous system disorder—Telmisartan—coronary artery disease	0.000934	0.00162	CcSEcCtD
Phentolamine—Abdominal pain—Lovastatin—coronary artery disease	0.000934	0.00162	CcSEcCtD
Phentolamine—Tachycardia—Telmisartan—coronary artery disease	0.00093	0.00161	CcSEcCtD
Phentolamine—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000927	0.00161	CcSEcCtD
Phentolamine—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000926	0.00161	CcSEcCtD
Phentolamine—Cardiac disorder—Timolol—coronary artery disease	0.000924	0.0016	CcSEcCtD
Phentolamine—Dizziness—Rosuvastatin—coronary artery disease	0.000921	0.0016	CcSEcCtD
Phentolamine—Nausea—Ticagrelor—coronary artery disease	0.00092	0.00159	CcSEcCtD
Phentolamine—Mediastinal disorder—Ramipril—coronary artery disease	0.000918	0.00159	CcSEcCtD
Phentolamine—Abdominal pain—Ezetimibe—coronary artery disease	0.000916	0.00159	CcSEcCtD
Phentolamine—Paraesthesia—Niacin—coronary artery disease	0.000911	0.00158	CcSEcCtD
Phentolamine—Arrhythmia—Ramipril—coronary artery disease	0.00091	0.00158	CcSEcCtD
Phentolamine—Hypotension—Trandolapril—coronary artery disease	0.000906	0.00157	CcSEcCtD
Phentolamine—Tachycardia—Captopril—coronary artery disease	0.000904	0.00157	CcSEcCtD
Phentolamine—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000903	0.00157	CcSEcCtD
Phentolamine—Angiopathy—Timolol—coronary artery disease	0.000903	0.00157	CcSEcCtD
Phentolamine—Hypotension—Enalapril—coronary artery disease	0.000903	0.00156	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000901	0.00156	CcSEcCtD
Phentolamine—Mediastinal disorder—Timolol—coronary artery disease	0.000897	0.00156	CcSEcCtD
Phentolamine—Paraesthesia—Pravastatin—coronary artery disease	0.000897	0.00155	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000896	0.00155	CcSEcCtD
Phentolamine—Abdominal pain—Eplerenone—coronary artery disease	0.000896	0.00155	CcSEcCtD
Phentolamine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000895	0.00155	CcSEcCtD
Phentolamine—Hypotension—Telmisartan—coronary artery disease	0.00089	0.00154	CcSEcCtD
Phentolamine—Arrhythmia—Timolol—coronary artery disease	0.000889	0.00154	CcSEcCtD
Phentolamine—Pain—Olmesartan—coronary artery disease	0.000888	0.00154	CcSEcCtD
Phentolamine—Nervous system disorder—Perindopril—coronary artery disease	0.000882	0.00153	CcSEcCtD
Phentolamine—Chest pain—Losartan—coronary artery disease	0.00088	0.00153	CcSEcCtD
Phentolamine—Tachycardia—Perindopril—coronary artery disease	0.000878	0.00152	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Niacin—coronary artery disease	0.000876	0.00152	CcSEcCtD
Phentolamine—Abdominal pain—Simvastatin—coronary artery disease	0.000873	0.00151	CcSEcCtD
Phentolamine—Headache—Rosuvastatin—coronary artery disease	0.000873	0.00151	CcSEcCtD
Phentolamine—Paraesthesia—Trandolapril—coronary artery disease	0.000871	0.00151	CcSEcCtD
Phentolamine—Asthenia—Fenofibrate—coronary artery disease	0.000868	0.0015	CcSEcCtD
Phentolamine—Pain—Niacin—coronary artery disease	0.000867	0.0015	CcSEcCtD
Phentolamine—Paraesthesia—Enalapril—coronary artery disease	0.000867	0.0015	CcSEcCtD
Phentolamine—Hypotension—Captopril—coronary artery disease	0.000866	0.0015	CcSEcCtD
Phentolamine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000861	0.00149	CcSEcCtD
Phentolamine—Nervous system disorder—Furosemide—coronary artery disease	0.000858	0.00149	CcSEcCtD
Phentolamine—Flushing—Lisinopril—coronary artery disease	0.000857	0.00149	CcSEcCtD
Phentolamine—Pruritus—Fenofibrate—coronary artery disease	0.000856	0.00148	CcSEcCtD
Phentolamine—Paraesthesia—Telmisartan—coronary artery disease	0.000855	0.00148	CcSEcCtD
Phentolamine—Pain—Pravastatin—coronary artery disease	0.000854	0.00148	CcSEcCtD
Phentolamine—Gastrointestinal pain—Valsartan—coronary artery disease	0.000853	0.00148	CcSEcCtD
Phentolamine—Asthenia—Clopidogrel—coronary artery disease	0.000853	0.00148	CcSEcCtD
Phentolamine—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000849	0.00147	CcSEcCtD
Phentolamine—Asthenia—Lovastatin—coronary artery disease	0.000847	0.00147	CcSEcCtD
Phentolamine—Pruritus—Clopidogrel—coronary artery disease	0.000841	0.00146	CcSEcCtD
Phentolamine—Hypotension—Perindopril—coronary artery disease	0.00084	0.00146	CcSEcCtD
Phentolamine—Angiopathy—Lisinopril—coronary artery disease	0.000838	0.00145	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000837	0.00145	CcSEcCtD
Phentolamine—Pruritus—Lovastatin—coronary artery disease	0.000836	0.00145	CcSEcCtD
Phentolamine—Mediastinal disorder—Lisinopril—coronary artery disease	0.000832	0.00144	CcSEcCtD
Phentolamine—Paraesthesia—Captopril—coronary artery disease	0.000832	0.00144	CcSEcCtD
Phentolamine—Asthenia—Ezetimibe—coronary artery disease	0.000831	0.00144	CcSEcCtD
Phentolamine—Gastrointestinal pain—Niacin—coronary artery disease	0.000829	0.00144	CcSEcCtD
Phentolamine—Nausea—Rosuvastatin—coronary artery disease	0.000828	0.00144	CcSEcCtD
Phentolamine—Diarrhoea—Fenofibrate—coronary artery disease	0.000828	0.00143	CcSEcCtD
Phentolamine—Nervous system disorder—Losartan—coronary artery disease	0.000827	0.00143	CcSEcCtD
Phentolamine—Arrhythmia—Lisinopril—coronary artery disease	0.000825	0.00143	CcSEcCtD
Phentolamine—Abdominal pain—Valsartan—coronary artery disease	0.000825	0.00143	CcSEcCtD
Phentolamine—Tachycardia—Losartan—coronary artery disease	0.000823	0.00143	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000823	0.00143	CcSEcCtD
Phentolamine—Abdominal pain—Olmesartan—coronary artery disease	0.000821	0.00142	CcSEcCtD
Phentolamine—Pruritus—Ezetimibe—coronary artery disease	0.000819	0.00142	CcSEcCtD
Phentolamine—Hypotension—Furosemide—coronary artery disease	0.000817	0.00142	CcSEcCtD
Phentolamine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000817	0.00142	CcSEcCtD
Phentolamine—Pain—Telmisartan—coronary artery disease	0.000815	0.00141	CcSEcCtD
Phentolamine—Diarrhoea—Clopidogrel—coronary artery disease	0.000813	0.00141	CcSEcCtD
Phentolamine—Asthenia—Eplerenone—coronary artery disease	0.000813	0.00141	CcSEcCtD
Phentolamine—Diarrhoea—Lovastatin—coronary artery disease	0.000808	0.0014	CcSEcCtD
Phentolamine—Paraesthesia—Perindopril—coronary artery disease	0.000808	0.0014	CcSEcCtD
Phentolamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000804	0.00139	CcSEcCtD
Phentolamine—Pruritus—Eplerenone—coronary artery disease	0.000802	0.00139	CcSEcCtD
Phentolamine—Abdominal pain—Niacin—coronary artery disease	0.000802	0.00139	CcSEcCtD
Phentolamine—Dizziness—Fenofibrate—coronary artery disease	0.0008	0.00139	CcSEcCtD
Phentolamine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000793	0.00137	CcSEcCtD
Phentolamine—Asthenia—Simvastatin—coronary artery disease	0.000793	0.00137	CcSEcCtD
Phentolamine—Diarrhoea—Ezetimibe—coronary artery disease	0.000793	0.00137	CcSEcCtD
Phentolamine—Gastrointestinal pain—Enalapril—coronary artery disease	0.00079	0.00137	CcSEcCtD
Phentolamine—Abdominal pain—Pravastatin—coronary artery disease	0.000789	0.00137	CcSEcCtD
Phentolamine—Hypotension—Losartan—coronary artery disease	0.000788	0.00137	CcSEcCtD
Phentolamine—Dizziness—Clopidogrel—coronary artery disease	0.000786	0.00136	CcSEcCtD
Phentolamine—Paraesthesia—Furosemide—coronary artery disease	0.000785	0.00136	CcSEcCtD
Phentolamine—Pruritus—Simvastatin—coronary artery disease	0.000782	0.00136	CcSEcCtD
Phentolamine—Dizziness—Lovastatin—coronary artery disease	0.000781	0.00135	CcSEcCtD
Phentolamine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000779	0.00135	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000777	0.00135	CcSEcCtD
Phentolamine—Diarrhoea—Eplerenone—coronary artery disease	0.000776	0.00134	CcSEcCtD
Phentolamine—Pain—Perindopril—coronary artery disease	0.000769	0.00133	CcSEcCtD
Phentolamine—Vomiting—Fenofibrate—coronary artery disease	0.000769	0.00133	CcSEcCtD
Phentolamine—Abdominal pain—Trandolapril—coronary artery disease	0.000767	0.00133	CcSEcCtD
Phentolamine—Dizziness—Ezetimibe—coronary artery disease	0.000766	0.00133	CcSEcCtD
Phentolamine—Abdominal pain—Enalapril—coronary artery disease	0.000764	0.00132	CcSEcCtD
Phentolamine—Headache—Fenofibrate—coronary artery disease	0.000758	0.00131	CcSEcCtD
Phentolamine—Paraesthesia—Losartan—coronary artery disease	0.000758	0.00131	CcSEcCtD
Phentolamine—Gastrointestinal pain—Captopril—coronary artery disease	0.000758	0.00131	CcSEcCtD
Phentolamine—Vomiting—Clopidogrel—coronary artery disease	0.000756	0.00131	CcSEcCtD
Phentolamine—Diarrhoea—Simvastatin—coronary artery disease	0.000756	0.00131	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000755	0.00131	CcSEcCtD
Phentolamine—Chest pain—Ramipril—coronary artery disease	0.000755	0.00131	CcSEcCtD
Phentolamine—Abdominal pain—Telmisartan—coronary artery disease	0.000753	0.00131	CcSEcCtD
Phentolamine—Vomiting—Lovastatin—coronary artery disease	0.000751	0.0013	CcSEcCtD
Phentolamine—Dizziness—Eplerenone—coronary artery disease	0.00075	0.0013	CcSEcCtD
Phentolamine—Asthenia—Valsartan—coronary artery disease	0.000748	0.0013	CcSEcCtD
Phentolamine—Hypertension—Timolol—coronary artery disease	0.000748	0.0013	CcSEcCtD
Phentolamine—Pain—Furosemide—coronary artery disease	0.000748	0.0013	CcSEcCtD
Phentolamine—Asthenia—Olmesartan—coronary artery disease	0.000745	0.00129	CcSEcCtD
Phentolamine—Headache—Clopidogrel—coronary artery disease	0.000745	0.00129	CcSEcCtD
Phentolamine—Headache—Lovastatin—coronary artery disease	0.00074	0.00128	CcSEcCtD
Phentolamine—Pruritus—Valsartan—coronary artery disease	0.000738	0.00128	CcSEcCtD
Phentolamine—Chest pain—Timolol—coronary artery disease	0.000738	0.00128	CcSEcCtD
Phentolamine—Vomiting—Ezetimibe—coronary artery disease	0.000736	0.00128	CcSEcCtD
Phentolamine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000736	0.00128	CcSEcCtD
Phentolamine—Pruritus—Olmesartan—coronary artery disease	0.000734	0.00127	CcSEcCtD
Phentolamine—Abdominal pain—Captopril—coronary artery disease	0.000732	0.00127	CcSEcCtD
Phentolamine—Dizziness—Simvastatin—coronary artery disease	0.00073	0.00127	CcSEcCtD
Phentolamine—Asthenia—Niacin—coronary artery disease	0.000728	0.00126	CcSEcCtD
Phentolamine—Headache—Ezetimibe—coronary artery disease	0.000726	0.00126	CcSEcCtD
Phentolamine—Pain—Losartan—coronary artery disease	0.000721	0.00125	CcSEcCtD
Phentolamine—Vomiting—Eplerenone—coronary artery disease	0.000721	0.00125	CcSEcCtD
Phentolamine—Nausea—Fenofibrate—coronary artery disease	0.000718	0.00125	CcSEcCtD
Phentolamine—Pruritus—Niacin—coronary artery disease	0.000718	0.00124	CcSEcCtD
Phentolamine—Asthenia—Pravastatin—coronary artery disease	0.000717	0.00124	CcSEcCtD
Phentolamine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000715	0.00124	CcSEcCtD
Phentolamine—Diarrhoea—Valsartan—coronary artery disease	0.000714	0.00124	CcSEcCtD
Phentolamine—Abdominal pain—Perindopril—coronary artery disease	0.000711	0.00123	CcSEcCtD
Phentolamine—Diarrhoea—Olmesartan—coronary artery disease	0.00071	0.00123	CcSEcCtD
Phentolamine—Headache—Eplerenone—coronary artery disease	0.00071	0.00123	CcSEcCtD
Phentolamine—Nervous system disorder—Ramipril—coronary artery disease	0.000709	0.00123	CcSEcCtD
Phentolamine—Pruritus—Pravastatin—coronary artery disease	0.000707	0.00123	CcSEcCtD
Phentolamine—Nausea—Clopidogrel—coronary artery disease	0.000706	0.00122	CcSEcCtD
Phentolamine—Tachycardia—Ramipril—coronary artery disease	0.000706	0.00122	CcSEcCtD
Phentolamine—Vomiting—Simvastatin—coronary artery disease	0.000702	0.00122	CcSEcCtD
Phentolamine—Nausea—Lovastatin—coronary artery disease	0.000701	0.00122	CcSEcCtD
Phentolamine—Asthenia—Trandolapril—coronary artery disease	0.000696	0.00121	CcSEcCtD
Phentolamine—Diarrhoea—Niacin—coronary artery disease	0.000694	0.0012	CcSEcCtD
Phentolamine—Nervous system disorder—Timolol—coronary artery disease	0.000694	0.0012	CcSEcCtD
Phentolamine—Asthenia—Enalapril—coronary artery disease	0.000693	0.0012	CcSEcCtD
Phentolamine—Headache—Simvastatin—coronary artery disease	0.000692	0.0012	CcSEcCtD
Phentolamine—Abdominal pain—Furosemide—coronary artery disease	0.000691	0.0012	CcSEcCtD
Phentolamine—Gastrointestinal pain—Losartan—coronary artery disease	0.00069	0.0012	CcSEcCtD
Phentolamine—Dizziness—Valsartan—coronary artery disease	0.00069	0.0012	CcSEcCtD
Phentolamine—Nausea—Ezetimibe—coronary artery disease	0.000688	0.00119	CcSEcCtD
Phentolamine—Dizziness—Olmesartan—coronary artery disease	0.000687	0.00119	CcSEcCtD
Phentolamine—Pruritus—Trandolapril—coronary artery disease	0.000686	0.00119	CcSEcCtD
Phentolamine—Chest pain—Lisinopril—coronary artery disease	0.000684	0.00119	CcSEcCtD
Phentolamine—Asthenia—Telmisartan—coronary artery disease	0.000684	0.00119	CcSEcCtD
Phentolamine—Pruritus—Enalapril—coronary artery disease	0.000683	0.00118	CcSEcCtD
Phentolamine—Diarrhoea—Pravastatin—coronary artery disease	0.000683	0.00118	CcSEcCtD
Phentolamine—Hypotension—Ramipril—coronary artery disease	0.000676	0.00117	CcSEcCtD
Phentolamine—Pruritus—Telmisartan—coronary artery disease	0.000674	0.00117	CcSEcCtD
Phentolamine—Nausea—Eplerenone—coronary artery disease	0.000673	0.00117	CcSEcCtD
Phentolamine—Dizziness—Niacin—coronary artery disease	0.000671	0.00116	CcSEcCtD
Phentolamine—Abdominal pain—Losartan—coronary artery disease	0.000667	0.00116	CcSEcCtD
Phentolamine—Asthenia—Captopril—coronary artery disease	0.000665	0.00115	CcSEcCtD
Phentolamine—Diarrhoea—Trandolapril—coronary artery disease	0.000664	0.00115	CcSEcCtD
Phentolamine—Vomiting—Valsartan—coronary artery disease	0.000663	0.00115	CcSEcCtD
Phentolamine—Diarrhoea—Enalapril—coronary artery disease	0.000661	0.00115	CcSEcCtD
Phentolamine—Hypotension—Timolol—coronary artery disease	0.000661	0.00115	CcSEcCtD
Phentolamine—Dizziness—Pravastatin—coronary artery disease	0.00066	0.00115	CcSEcCtD
Phentolamine—Vomiting—Olmesartan—coronary artery disease	0.00066	0.00114	CcSEcCtD
Phentolamine—Nausea—Simvastatin—coronary artery disease	0.000656	0.00114	CcSEcCtD
Phentolamine—Pruritus—Captopril—coronary artery disease	0.000655	0.00114	CcSEcCtD
Phentolamine—Headache—Valsartan—coronary artery disease	0.000654	0.00113	CcSEcCtD
Phentolamine—Diarrhoea—Telmisartan—coronary artery disease	0.000652	0.00113	CcSEcCtD
Phentolamine—Headache—Olmesartan—coronary artery disease	0.00065	0.00113	CcSEcCtD
Phentolamine—Paraesthesia—Ramipril—coronary artery disease	0.00065	0.00113	CcSEcCtD
Phentolamine—Asthenia—Perindopril—coronary artery disease	0.000645	0.00112	CcSEcCtD
Phentolamine—Vomiting—Niacin—coronary artery disease	0.000645	0.00112	CcSEcCtD
Phentolamine—Dizziness—Trandolapril—coronary artery disease	0.000641	0.00111	CcSEcCtD
Phentolamine—Tachycardia—Lisinopril—coronary artery disease	0.00064	0.00111	CcSEcCtD
Phentolamine—Dizziness—Enalapril—coronary artery disease	0.000639	0.00111	CcSEcCtD
Phentolamine—Pruritus—Perindopril—coronary artery disease	0.000636	0.0011	CcSEcCtD
Phentolamine—Headache—Niacin—coronary artery disease	0.000635	0.0011	CcSEcCtD
Phentolamine—Paraesthesia—Timolol—coronary artery disease	0.000635	0.0011	CcSEcCtD
Phentolamine—Vomiting—Pravastatin—coronary artery disease	0.000635	0.0011	CcSEcCtD
Phentolamine—Diarrhoea—Captopril—coronary artery disease	0.000634	0.0011	CcSEcCtD
Phentolamine—Dizziness—Telmisartan—coronary artery disease	0.00063	0.00109	CcSEcCtD
Phentolamine—Asthenia—Furosemide—coronary artery disease	0.000627	0.00109	CcSEcCtD
Phentolamine—Headache—Pravastatin—coronary artery disease	0.000626	0.00108	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000625	0.00108	CcSEcCtD
Phentolamine—Nausea—Valsartan—coronary artery disease	0.00062	0.00107	CcSEcCtD
Phentolamine—Pruritus—Furosemide—coronary artery disease	0.000619	0.00107	CcSEcCtD
Phentolamine—Nausea—Olmesartan—coronary artery disease	0.000617	0.00107	CcSEcCtD
Phentolamine—Vomiting—Trandolapril—coronary artery disease	0.000617	0.00107	CcSEcCtD
Phentolamine—Diarrhoea—Perindopril—coronary artery disease	0.000615	0.00107	CcSEcCtD
Phentolamine—Vomiting—Enalapril—coronary artery disease	0.000614	0.00106	CcSEcCtD
Phentolamine—Hypotension—Lisinopril—coronary artery disease	0.000613	0.00106	CcSEcCtD
Phentolamine—Dizziness—Captopril—coronary artery disease	0.000613	0.00106	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000611	0.00106	CcSEcCtD
Phentolamine—Headache—Trandolapril—coronary artery disease	0.000608	0.00105	CcSEcCtD
Phentolamine—Vomiting—Telmisartan—coronary artery disease	0.000606	0.00105	CcSEcCtD
Phentolamine—Asthenia—Losartan—coronary artery disease	0.000605	0.00105	CcSEcCtD
Phentolamine—Headache—Enalapril—coronary artery disease	0.000605	0.00105	CcSEcCtD
Phentolamine—Pain—Timolol—coronary artery disease	0.000605	0.00105	CcSEcCtD
Phentolamine—Nausea—Niacin—coronary artery disease	0.000602	0.00104	CcSEcCtD
Phentolamine—Diarrhoea—Furosemide—coronary artery disease	0.000598	0.00104	CcSEcCtD
Phentolamine—Pruritus—Losartan—coronary artery disease	0.000597	0.00103	CcSEcCtD
Phentolamine—Headache—Telmisartan—coronary artery disease	0.000597	0.00103	CcSEcCtD
Phentolamine—Dizziness—Perindopril—coronary artery disease	0.000595	0.00103	CcSEcCtD
Phentolamine—Nausea—Pravastatin—coronary artery disease	0.000593	0.00103	CcSEcCtD
Phentolamine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000592	0.00103	CcSEcCtD
Phentolamine—Paraesthesia—Lisinopril—coronary artery disease	0.000589	0.00102	CcSEcCtD
Phentolamine—Vomiting—Captopril—coronary artery disease	0.000589	0.00102	CcSEcCtD
Phentolamine—Headache—Captopril—coronary artery disease	0.00058	0.00101	CcSEcCtD
Phentolamine—Gastrointestinal pain—Timolol—coronary artery disease	0.000578	0.001	CcSEcCtD
Phentolamine—Dizziness—Furosemide—coronary artery disease	0.000578	0.001	CcSEcCtD
Phentolamine—Diarrhoea—Losartan—coronary artery disease	0.000577	0.001	CcSEcCtD
Phentolamine—Nausea—Trandolapril—coronary artery disease	0.000576	0.000999	CcSEcCtD
Phentolamine—Nausea—Enalapril—coronary artery disease	0.000574	0.000995	CcSEcCtD
Phentolamine—Vomiting—Perindopril—coronary artery disease	0.000572	0.000992	CcSEcCtD
Phentolamine—Abdominal pain—Ramipril—coronary artery disease	0.000572	0.000992	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000566	0.000982	CcSEcCtD
Phentolamine—Nausea—Telmisartan—coronary artery disease	0.000566	0.000981	CcSEcCtD
Phentolamine—Headache—Perindopril—coronary artery disease	0.000563	0.000977	CcSEcCtD
Phentolamine—Pain—Lisinopril—coronary artery disease	0.000561	0.000973	CcSEcCtD
Phentolamine—Abdominal pain—Timolol—coronary artery disease	0.000559	0.000969	CcSEcCtD
Phentolamine—Dizziness—Losartan—coronary artery disease	0.000558	0.000967	CcSEcCtD
Phentolamine—Vomiting—Furosemide—coronary artery disease	0.000556	0.000964	CcSEcCtD
Phentolamine—Nausea—Captopril—coronary artery disease	0.00055	0.000954	CcSEcCtD
Phentolamine—Headache—Furosemide—coronary artery disease	0.000548	0.00095	CcSEcCtD
Phentolamine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000536	0.00093	CcSEcCtD
Phentolamine—Vomiting—Losartan—coronary artery disease	0.000536	0.00093	CcSEcCtD
Phentolamine—Nausea—Perindopril—coronary artery disease	0.000534	0.000926	CcSEcCtD
Phentolamine—Headache—Losartan—coronary artery disease	0.000529	0.000916	CcSEcCtD
Phentolamine—Nausea—Furosemide—coronary artery disease	0.000519	0.000901	CcSEcCtD
Phentolamine—Asthenia—Ramipril—coronary artery disease	0.000519	0.0009	CcSEcCtD
Phentolamine—Abdominal pain—Lisinopril—coronary artery disease	0.000519	0.000899	CcSEcCtD
Phentolamine—Pruritus—Ramipril—coronary artery disease	0.000512	0.000887	CcSEcCtD
Phentolamine—Asthenia—Timolol—coronary artery disease	0.000507	0.00088	CcSEcCtD
Phentolamine—Nausea—Losartan—coronary artery disease	0.000501	0.000869	CcSEcCtD
Phentolamine—Pruritus—Timolol—coronary artery disease	0.0005	0.000868	CcSEcCtD
Phentolamine—Diarrhoea—Ramipril—coronary artery disease	0.000495	0.000858	CcSEcCtD
Phentolamine—Diarrhoea—Timolol—coronary artery disease	0.000484	0.000839	CcSEcCtD
Phentolamine—Dizziness—Ramipril—coronary artery disease	0.000478	0.000829	CcSEcCtD
Phentolamine—Asthenia—Lisinopril—coronary artery disease	0.000471	0.000816	CcSEcCtD
Phentolamine—Dizziness—Timolol—coronary artery disease	0.000468	0.000811	CcSEcCtD
Phentolamine—Pruritus—Lisinopril—coronary artery disease	0.000464	0.000805	CcSEcCtD
Phentolamine—Vomiting—Ramipril—coronary artery disease	0.00046	0.000797	CcSEcCtD
Phentolamine—Headache—Ramipril—coronary artery disease	0.000453	0.000786	CcSEcCtD
Phentolamine—Vomiting—Timolol—coronary artery disease	0.00045	0.00078	CcSEcCtD
Phentolamine—Diarrhoea—Lisinopril—coronary artery disease	0.000449	0.000778	CcSEcCtD
Phentolamine—Headache—Timolol—coronary artery disease	0.000443	0.000768	CcSEcCtD
Phentolamine—Dizziness—Lisinopril—coronary artery disease	0.000434	0.000752	CcSEcCtD
Phentolamine—Nausea—Ramipril—coronary artery disease	0.00043	0.000745	CcSEcCtD
Phentolamine—Nausea—Timolol—coronary artery disease	0.00042	0.000728	CcSEcCtD
Phentolamine—Vomiting—Lisinopril—coronary artery disease	0.000417	0.000723	CcSEcCtD
Phentolamine—Headache—Lisinopril—coronary artery disease	0.000411	0.000713	CcSEcCtD
Phentolamine—Nausea—Lisinopril—coronary artery disease	0.00039	0.000676	CcSEcCtD
Phentolamine—ADRA1D—Signaling Pathways—POMC—coronary artery disease	1.83e-05	4.33e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	1.83e-05	4.33e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—AKT1—coronary artery disease	1.83e-05	4.32e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOB—coronary artery disease	1.83e-05	4.31e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	1.82e-05	4.29e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FN1—coronary artery disease	1.82e-05	4.29e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—F2—coronary artery disease	1.82e-05	4.29e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	1.81e-05	4.29e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	1.81e-05	4.28e-05	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	1.81e-05	4.28e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6ST—coronary artery disease	1.81e-05	4.27e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AGT—coronary artery disease	1.81e-05	4.27e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	1.8e-05	4.26e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOE—coronary artery disease	1.8e-05	4.25e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—LEP—coronary artery disease	1.8e-05	4.25e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	1.8e-05	4.25e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NFKBIA—coronary artery disease	1.8e-05	4.24e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	1.79e-05	4.24e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	1.79e-05	4.22e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—AGT—coronary artery disease	1.78e-05	4.21e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	1.78e-05	4.21e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOA1—coronary artery disease	1.78e-05	4.2e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—LEP—coronary artery disease	1.77e-05	4.18e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOE—coronary artery disease	1.77e-05	4.18e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	1.77e-05	4.18e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	1.76e-05	4.17e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KDR—coronary artery disease	1.76e-05	4.17e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	1.76e-05	4.16e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	1.76e-05	4.15e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	1.76e-05	4.15e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	1.75e-05	4.15e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK14—coronary artery disease	1.75e-05	4.14e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	1.75e-05	4.14e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOE—coronary artery disease	1.75e-05	4.13e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LPL—coronary artery disease	1.74e-05	4.12e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KIT—coronary artery disease	1.74e-05	4.11e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KDR—coronary artery disease	1.73e-05	4.1e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	1.73e-05	4.09e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	1.73e-05	4.08e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	1.73e-05	4.08e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOA1—coronary artery disease	1.73e-05	4.08e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	1.72e-05	4.07e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ESR1—coronary artery disease	1.72e-05	4.06e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—F2—coronary artery disease	1.7e-05	4.01e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FN1—coronary artery disease	1.7e-05	4.01e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	1.69e-05	4e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	1.69e-05	3.99e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6ST—coronary artery disease	1.69e-05	3.99e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—C3—coronary artery disease	1.69e-05	3.99e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—coronary artery disease	1.69e-05	3.98e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	1.68e-05	3.98e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NFKBIA—coronary artery disease	1.68e-05	3.96e-05	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	1.68e-05	3.96e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	1.67e-05	3.96e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—F2—coronary artery disease	1.67e-05	3.95e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FN1—coronary artery disease	1.67e-05	3.95e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	1.67e-05	3.94e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	1.66e-05	3.93e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—POMC—coronary artery disease	1.65e-05	3.91e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	1.65e-05	3.91e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	1.65e-05	3.9e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	1.64e-05	3.88e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	1.64e-05	3.87e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KIT—coronary artery disease	1.62e-05	3.84e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	1.62e-05	3.83e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	1.62e-05	3.83e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	1.61e-05	3.81e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—coronary artery disease	1.61e-05	3.81e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	1.61e-05	3.81e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	1.61e-05	3.8e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AGT—coronary artery disease	1.61e-05	3.79e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	1.6e-05	3.78e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KIT—coronary artery disease	1.6e-05	3.78e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	1.59e-05	3.76e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	1.58e-05	3.74e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LEP—coronary artery disease	1.57e-05	3.72e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOE—coronary artery disease	1.57e-05	3.72e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	1.57e-05	3.71e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—C3—coronary artery disease	1.57e-05	3.71e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	1.56e-05	3.68e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	1.55e-05	3.67e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	1.55e-05	3.67e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—POMC—coronary artery disease	1.55e-05	3.65e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	1.55e-05	3.65e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KDR—coronary artery disease	1.54e-05	3.64e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	1.53e-05	3.62e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	1.53e-05	3.62e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	1.52e-05	3.6e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARG—coronary artery disease	1.52e-05	3.6e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—POMC—coronary artery disease	1.52e-05	3.59e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	1.52e-05	3.59e-05	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.51e-05	3.58e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	1.51e-05	3.57e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	1.51e-05	3.57e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	1.51e-05	3.56e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	1.5e-05	3.55e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—POMC—coronary artery disease	1.5e-05	3.55e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	1.5e-05	3.54e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	1.49e-05	3.52e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	1.49e-05	3.52e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	1.49e-05	3.51e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—AKT1—coronary artery disease	1.48e-05	3.51e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	1.48e-05	3.51e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FN1—coronary artery disease	1.48e-05	3.5e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—F2—coronary artery disease	1.48e-05	3.5e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	1.48e-05	3.5e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	1.48e-05	3.49e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—coronary artery disease	1.47e-05	3.48e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	1.47e-05	3.46e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	1.46e-05	3.46e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	1.46e-05	3.46e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	1.46e-05	3.45e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	1.46e-05	3.45e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	1.46e-05	3.44e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	1.44e-05	3.41e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	1.44e-05	3.41e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	1.43e-05	3.38e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.42e-05	3.36e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KIT—coronary artery disease	1.42e-05	3.35e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	1.42e-05	3.35e-05	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.41e-05	3.34e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	1.41e-05	3.34e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	1.4e-05	3.31e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.4e-05	3.3e-05	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.39e-05	3.29e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	1.39e-05	3.28e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.38e-05	3.26e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.38e-05	3.26e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	1.37e-05	3.25e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1.37e-05	3.24e-05	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	1.37e-05	3.24e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—coronary artery disease	1.37e-05	3.23e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	1.37e-05	3.23e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	1.36e-05	3.22e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	1.36e-05	3.22e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	1.36e-05	3.21e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	1.35e-05	3.19e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—POMC—coronary artery disease	1.35e-05	3.19e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	1.35e-05	3.19e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	1.35e-05	3.19e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	1.35e-05	3.18e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	1.33e-05	3.13e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	1.32e-05	3.12e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	1.32e-05	3.12e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.32e-05	3.12e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	1.32e-05	3.11e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	1.31e-05	3.1e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—coronary artery disease	1.31e-05	3.09e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	1.3e-05	3.07e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	1.29e-05	3.06e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	1.29e-05	3.05e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.28e-05	3.03e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	1.28e-05	3.03e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.28e-05	3.02e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.27e-05	2.99e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.26e-05	2.99e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.26e-05	2.97e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.26e-05	2.97e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	1.24e-05	2.94e-05	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.24e-05	2.92e-05	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.24e-05	2.92e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.23e-05	2.92e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.23e-05	2.9e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.23e-05	2.89e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.22e-05	2.89e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.22e-05	2.88e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.21e-05	2.85e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.2e-05	2.84e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.2e-05	2.83e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.2e-05	2.83e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.19e-05	2.82e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.19e-05	2.82e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.18e-05	2.78e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.18e-05	2.78e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.16e-05	2.74e-05	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.16e-05	2.73e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	1.15e-05	2.72e-05	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.15e-05	2.71e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.15e-05	2.71e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.15e-05	2.71e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.14e-05	2.7e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.14e-05	2.69e-05	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.14e-05	2.69e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.13e-05	2.66e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.12e-05	2.65e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.12e-05	2.65e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.12e-05	2.64e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	1.11e-05	2.63e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.11e-05	2.62e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.1e-05	2.59e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.09e-05	2.59e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	1.08e-05	2.56e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	1.06e-05	2.51e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.06e-05	2.51e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	1.06e-05	2.5e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	1.05e-05	2.48e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.05e-05	2.47e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.04e-05	2.46e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	1.04e-05	2.46e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	1.04e-05	2.45e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	1.03e-05	2.44e-05	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1.01e-05	2.39e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	1e-05	2.36e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	9.94e-06	2.35e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	9.74e-06	2.3e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	9.71e-06	2.29e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	9.71e-06	2.29e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	9.56e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	9.54e-06	2.25e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	9.45e-06	2.23e-05	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	9.38e-06	2.22e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	9.36e-06	2.21e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	9.3e-06	2.2e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	9.24e-06	2.18e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	9.17e-06	2.17e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	9.07e-06	2.14e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	9.05e-06	2.14e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	8.99e-06	2.13e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	8.91e-06	2.11e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	8.78e-06	2.08e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	8.77e-06	2.07e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	8.74e-06	2.07e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	8.6e-06	2.03e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	8.52e-06	2.01e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	8.49e-06	2.01e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	8.12e-06	1.92e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	7.96e-06	1.88e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	7.89e-06	1.86e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	7.79e-06	1.84e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	7.64e-06	1.81e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	7.59e-06	1.79e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	7.47e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—AKT1—coronary artery disease	7.41e-06	1.75e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	7.37e-06	1.74e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	7.35e-06	1.74e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	7.24e-06	1.71e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	7.19e-06	1.7e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	7.1e-06	1.68e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	6.72e-06	1.59e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	6.63e-06	1.57e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	6.63e-06	1.57e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	6.61e-06	1.56e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	6.2e-06	1.46e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	6.16e-06	1.46e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	6.1e-06	1.44e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—AKT1—coronary artery disease	6.02e-06	1.42e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	5.87e-06	1.39e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	5.46e-06	1.29e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	5.42e-06	1.28e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	5.03e-06	1.19e-05	CbGpPWpGaD
